Important Deadlines for Investors
Investors in Spirit Aviation Holdings, Inc. (OTC: FLYYQ), Molina Healthcare, Inc. (NYSE: MOH), Skye Bioscience, Inc. (NASDAQ: SKYE), and Perrigo Company plc (NYSE: PRGO) should be aware of upcoming class action deadlines. As the landscape of investment continues to shift, it is crucial for shareholders to stay informed and act promptly to protect their investments.
Spirit Aviation Holdings, Inc.
Spirit Aviation Holdings has recently undergone significant changes, including a bankruptcy reorganization. Stockholders have a class period running from May 28, 2025, to August 29, 2025. The lead plaintiff deadline is set for December 1, 2025. During this period, investors alleged that Spirit failed to disclose crucial information regarding their financial risks. Concerns were raised about the company's ability to meet its debt obligations and the potential for needing further bankruptcy protection.
Class Action Details
In late August 2025, Spirit disclosed that it had filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court. This announcement led to a significant drop in the stock price, changing the market dynamics for FLYYQ traders. Investors are encouraged to gather more information to assess the implications of this lawsuit and how they may affect their holdings.
Molina Healthcare, Inc.
For those invested in Molina Healthcare (NYSE: MOH), it’s essential to note that the class period spans from February 5, 2025, to July 23, 2025, with a lead plaintiff deadline of December 2, 2025. Allegations against Molina include misleading statements about the company’s medical cost trends and overall financial health.
Understanding the Accusations
The lawsuit alleges Molina had material adverse information affecting its growth and profitability. These claims could have a long-lasting impact on investor confidence and the future performance of the stock. Potential investors or those already holding shares are advised to stay updated with developments regarding this class action.
Skye Bioscience, Inc.
Investors in Skye Bioscience, Inc. (NASDAQ: SKYE) should also pay attention. The class period for this company extends from November 4, 2024, to October 3, 2025. The lead plaintiff submission deadline is January 16, 2026. Reports allege discrepancies in the efficacy of Skye’s drug nimacimab, affecting its market position and investor expectations.
The Impact of Findings
In October 2025, Skye announced the results of its clinical study, noting that expectations for the drug were overstated. This announcement resulted in a decrease in stock value, emphasizing the need for shareholders to be proactive about their investments in such firms.
Perrigo Company plc
Perrigo (NYSE: PRGO) experiences its own turbulence, with claims covering the class period from February 27, 2023, to November 4, 2025. Investors must note that the deadline to serve as lead plaintiff is January 16, 2026. Allegations focus on failures to disclose important information about the company's infant formula operations, leading to significant changes in financial forecasts.
Financial Outlook Post-Crisis
Following the latest press releases, Perrigo's financial results faced scrutiny, and the company's stock price witnessed a downward trend. This calls for shareholders to consider the evolving circumstances surrounding their investments and seek legal advice as necessary.
About Bragar Eagel & Squire, P.C.
Bragar Eagel & Squire, P.C. operates as a law firm specializing in litigation on behalf of investors. Their expertise in handling cases across securities, commercial, and consumer protection makes them a valuable resource for investors affected by these class actions.
Contact Information
If you need assistance or more information regarding these cases, Bragar Eagel & Squire, P.C. can be contacted at:
Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Melissa Fortunato, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com
Frequently Asked Questions
What are class action lawsuits?
Class action lawsuits are legal proceedings where a group of people collectively bring a claim to court against a defendant, typically involving common grievances.
How does a lead plaintiff participate in a class action?
The lead plaintiff represents the interests of the entire class and is responsible for overseeing the case's progress.
What should I do if I invested in these companies?
Stay informed about class action developments and consider consulting with legal advisors regarding your options.
Are there risks involved with investing in stocks facing lawsuits?
Yes, investing in companies under legal scrutiny can lead to volatility in stock prices and potentially financial loss.
Can I recover losses from a class action lawsuit?
If the class action is successful, affected shareholders may receive compensation, although recovery amounts can vary widely.
